Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A [Phase 1]

View source ↗

Summary

Phase 1 trial update on ascending oral doses of MMV390048 focusing on safety, tolerability, and pharmacokinetics in malaria patients; results posted after compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MMV390048 (MMV390048)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2020-06-11